MALAT1 expression is considerably higher in DN patients than in T2DM patients, and it can be utilized to identify DN in conjunction with other biomarkers (ACR, creatinine, and 1-MG) (26, 28). This evidence concerns the gene MALAT1 and type 2 diabetes mellitus.